Latest stock market podcasts

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and the company’s healthy cash balance.

Weekly Wrap 17 April

Bell Direct

April 17, 2026

From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon

Bell Direct

April 2, 2026

From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter

Bell Direct

April 2, 2026

From the helm: Titomic Ltd, CFO, Geoff Hollis

Bell Direct

April 1, 2026

From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder

Bell Direct

April 1, 2026

From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO

Bell Direct

April 1, 2026

Navigating geopolitical turbulence:The strategic case for defence technology

Bell Direct

March 31, 2026

Weekly Wrap 27 March

Bell Direct

March 27, 2026

From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.

Bell Direct

March 20, 2026

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct

March 20, 2026

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct

March 20, 2026

From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan

Bell Direct

March 20, 2026